- Prescription Drug User Fee Act (PDUFA) target action date is February 28, 2025 -
- Product has patent protection through 2043 -
July 15, 2024 -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the Company’s New Drug Application (NDA) for ET-400, a proprietary patented formulation of hydrocortisone oral solution, has been accepted by the U.S. Food an